▲ Peaking
Business
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.
Gilead's Trodelvy
1 news trends Newsylist has tracked involving Gilead's Trodelvy — newest first.